my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
05-07-2012: Biocitech and AP-HP announced that they have signed a cooperation agreement. The agreement was signed by Mireille Faugere, managing director of AP-HP and Jean-Francois Boussard, Biocitech president, at the ninth annual APinnov technology transfer conference in Paris.
Together, the two partners intend to accelerate the creation and scientific development of early-stage life sciences enterprises. Those with projects to propose from AP-HP will be able to use premises at Biocitech, near central Paris, on favorable terms while Biocitech residents will have special access to technological innovations originating in AP-HP. Agreements will cover areas such as technology transfer, co-development or clinical development.
There will be a joint development and oversight committee with representatives from OTTLIV, the technology transfer arm of AP-HP, and from Biocitech. They will be responsible for ensuring the smooth running of joint actions. The committee will take decisions on companies moving into Biocitech with technology originating from AP-HP, on Biocitech residents wanting to access AP-HOP technology and on requests from Biocitech residents wishing to have their medicines evaluated in clinical trials at AP-HP.
Watchlist
This is where you can add this news to your personal favourites
Biocitech gives support to three start-ups in Bond’Innov initiative
Biocitech announced that it is giving its support to three new biotechnology start-ups based in the town of Bondy, near Paris. The announcement came after the official opening of Bond’Innov, an incubator backed by various public bodies and by Biocitech. Biocitech was one of the founding par ... more
Biocitech: Mutabilis receives EUR four million of EU funding for its HIVINNOV project
Mutabilis announced that it has received EUR four million of European funding for the HIVINNOV project, which is aimed at developing new antiretrovirals against HIV. The Mutabilis project, known as “Generation of a new class of antiretrovirals targeting HIV-cellular cofactors interactions ... more
Paris hospitals group, AP-HP, and Biocitech sign cooperation agreement
Biocitech and AP-HP announced that they have signed a cooperation agreement. The agreement was signed by Mireille Faugere, managing director of AP-HP and Jean-Francois Boussard, Biocitech president, at the ninth annual APinnov technology transfer conference in Paris. Together, the two partn ... more
The Biocitech technology park for life sciences offers a world-class environment and services for the development of biotechnology, biopharmaceutical and fine chemical companies. Biocitech is on the outskirts of Paris, only 20 minutes from the city center and Charles de Gaulle airport. It i ... more
Paris hospitals group, AP-HP, and Biocitech sign cooperation agreement
Biocitech and AP-HP announced that they have signed a cooperation agreement. The agreement was signed by Mireille Faugere, managing director of AP-HP and Jean-Francois Boussard, Biocitech president, at the ninth annual APinnov technology transfer conference in Paris. Together, the two partn ... more
Assistance Publique-Hôpitaux de Paris (AP-HP)
AP-HP (Assistance Publique – Hopitaux de Paris) brings together 37 Paris hospitals, including university and teaching establishments, and enjoys close associations with world-famous bodies such as Inserm, the CNRS, the Institut Curie, the Institut Gustav Roussy, the Institut Pasteur, and Fr ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
